Syndax Pharmaceuticals Inc (SNDX)
20.57
-0.22
(-1.06%)
USD |
NASDAQ |
Apr 25, 16:00
20.58
+0.01
(+0.05%)
Pre-Market: 20:00
Syndax Pharmaceuticals Shareholders Equity (Quarterly): 554.20M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 554.20M |
| September 30, 2023 | 359.19M |
| June 30, 2023 | 400.04M |
| March 31, 2023 | 435.50M |
| December 31, 2022 | 467.45M |
| September 30, 2022 | 338.10M |
| June 30, 2022 | 361.94M |
| March 31, 2022 | 374.55M |
| December 31, 2021 | 408.37M |
| September 30, 2021 | 199.00M |
| June 30, 2021 | 214.56M |
| March 31, 2021 | 228.20M |
| December 31, 2020 | 252.19M |
| September 30, 2020 | 131.98M |
| June 30, 2020 | 147.65M |
| March 31, 2020 | 53.51M |
| December 31, 2019 | 31.60M |
| September 30, 2019 | 44.04M |
| June 30, 2019 | 55.28M |
| March 31, 2019 | 68.63M |
| Date | Value |
|---|---|
| December 31, 2018 | 53.05M |
| September 30, 2018 | 64.27M |
| June 30, 2018 | 70.35M |
| March 31, 2018 | 86.95M |
| December 31, 2017 | 104.32M |
| September 30, 2017 | 96.71M |
| June 30, 2017 | 109.34M |
| March 31, 2017 | 72.62M |
| December 31, 2016 | 84.14M |
| September 30, 2016 | 93.83M |
| June 30, 2016 | 106.24M |
| March 31, 2016 | 113.85M |
| December 31, 2015 | 66.70M |
| September 30, 2015 | 70.76M |
| December 31, 2014 | -5.716M |
| September 30, 2014 | -2.578M |
| June 30, 2014 | 4.31M |
| March 31, 2014 | 8.433M |
| December 31, 2013 | 11.85M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.60M
Minimum
Dec 2019
554.20M
Maximum
Dec 2023
266.18M
Average
252.19M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| SpringWorks Therapeutics Inc | 626.22M |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Geron Corp | 247.95M |
| Ionis Pharmaceuticals Inc | 386.69M |
| Madrigal Pharmaceuticals Inc | 405.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 612.88M |
| Total Liabilities (Quarterly) | 58.68M |